Results 181 to 190 of about 71,892 (273)

Investigation of furo[2,3-h]- and pyridazino[3,4-f]cinnolin-3-ol scaffolds as substrates for the development of novel HIV-1 integrase inhibitors

, 2011
Mohamed F. Y. Gomaa, Nicolino Pala, Marco Derudas, Jehan Abd-Elrazik Hasanen, Elsayed H. Eltamany, Paola Casule, Alberto Mariani, Mario Sechi   +7 more
openalex   +2 more sources

Lack of Resistance to Integrase Inhibitors among Antiretroviral-Naive Subjects with Primary HIV-1 Infection, 2007–2013 [PDF]

, 2014
Joanne D. Stekler, Jennifer L. McKernan, Ross Milne, Kenneth Tapia, Kateryna Mykhalchenko, Sarah Holte, Janine Maenza, Claire E. Stevens, Susan E. Buskin, James I. Mullins, Lisa M. Frenkel, Ann C. Collier   +11 more
openalex   +1 more source

Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018-2022. [PDF]

Front Cell Infect Microbiol
Lu X, Li Y, Liu M, Wang Y, An N, Sun D, Li Q.   +6 more
europepmc   +1 more source

Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes

, 2011
Kendra E. Hightower, Ruolan Wang, Felix Deanda, Brian A. Johns, Kurt Weaver, Yingnian Shen, Ginger H. Tomberlin, H. Luke Carter, Timothy M Broderick, Sigethy Scott, Takahiro Seki, Masanori Kobayashi, Mark Underwood   +12 more
openalex   +1 more source

Alternaria alternata (Fr) Keissl Crude Extract Inhibits HIV Subtypes and Integrase Drug-Resistant Strains at Different Stages of HIV Replication. [PDF]

Pharmaceuticals (Basel)
Naidu D, Oduro-Kwateng E, Soliman MES, Ndlovu SI, Mkhwanazi NP.   +4 more
europepmc   +1 more source

Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3'-Processing Suppression. [PDF]

Pharmaceuticals (Basel)
Sayyed SK, Quraishi M, Prabakaran DS, Chandrasekaran B, Ramesh T, Rajasekharan SK, Raorane CJ, Sonawane T, Ravichandran V.   +8 more
europepmc   +1 more source

Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France [PDF]

, 2014
Nicolas Despiégel, Anne-Geneviève Marcellin, C. Aubin, Caroline Espinas, Audrey Laurisse, Gilles Pialoux   +5 more
openalex   +1 more source

High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana. [PDF]

J Antimicrob Chemother
Choga OT, Lemogang GM, Choga WT, Muzanywa G, Shadreck TM, Ralegoreng C, Maruapula D, Moraka NO, Koofhethile CK, Mokgethi PT, Seru K, Zuze BJL, Montshosi P, Gobe I, Motswaledi MS, Musonda R, Mbulawa MB, Makhema J, Shapiro R, Lockman S, Chebani T, Nawa J, Bochena L, Moyo S, Gaseitsiwe S.   +24 more
europepmc   +1 more source

Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals [PDF]

, 2015
Teresa Llácer Delicado, Esther Torrecilla, África Holguín   +2 more
openalex   +1 more source

Viral suppression in the context of SARS-CoV-2 among children infected with HIV-1 monitored in five health facilities in Benin. [PDF]

BMC Infect Dis
Dagba Gbessin EH, Gomgnimbou MK, Keke RK, Sina H, Afangnihoun A, Bachabi M, Ouedraogo AS, Baba-Moussa L.   +7 more
europepmc   +1 more source